BeyondSpring Pharmaceuticals: Communicating across US-China lines

Aug 07, 2017
Newly listed immuno-oncology firm on its post-IPO goals, small-cap challenges and drugs trials in the US and China
Dr Lan Huang is co-founder, chairman and CEO of a New York-headquartered clinical-stage company within a regulatory framework that sees the firm conduct trials both in the US, where the company is based and listed, and in China. ‘We have a robust pipeline from

Content Preview

to continue reading

  • Unlimited news online
  • Newsletter
Sign up to get stories direct to your inbox
logo-black logo-black